US BANCORP \DE\ - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$9,000
+200.0%
2,851
+143.5%
0.00%
Q1 2020$3,0000.0%1,1710.0%0.00%
Q4 2019$3,000
+200.0%
1,171
+57.0%
0.00%
Q3 2019$1,000
-50.0%
7460.0%0.00%
Q2 2019$2,0000.0%746
+31.6%
0.00%
Q1 2019$2,000
-33.3%
567
-43.3%
0.00%
Q1 2018$3,000
+200.0%
1,000
+233.3%
0.00%
Q2 2017$1,0000.0%3000.0%0.00%
Q1 2017$1,0000.0%3000.0%0.00%
Q4 2016$1,000
-66.7%
300
-62.9%
0.00%
Q3 2016$3,000
-25.0%
809
-33.1%
0.00%
Q2 2016$4,0000.0%1,2090.0%0.00%
Q1 2016$4,000
+100.0%
1,209
+72.7%
0.00%
Q4 2015$2,000
-50.0%
7000.0%0.00%
Q3 2015$4,000
-75.0%
700
-72.4%
0.00%
Q2 2015$16,000
-52.9%
2,533
-46.2%
0.00%
Q1 2015$34,000
-61.8%
4,708
-59.3%
0.00%
Q4 2014$89,000
+4.7%
11,576
+1.9%
0.00%
Q3 2014$85,000
-30.3%
11,358
-10.3%
0.00%
Q2 2014$122,000
+15.1%
12,6680.0%0.00%
Q1 2014$106,000
+12.8%
12,668
+14.1%
0.00%
Q4 2013$94,000
+1075.0%
11,098
+1009.8%
0.00%
Q3 2013$8,0000.0%1,0000.0%0.00%
Q2 2013$8,0001,0000.00%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders